New investigational drug for Follicular Lymphoma

Trial ID:
IRB-24-8469
Marin Xavier, MD

Inclusion Criteria

Patients must:

  • Be at least 18 years old
    Have CD20+, histologically confirmed classic Follicular Lymphoma based on most recent tumor biopsy
    Be in need of systemic treatment

Exclusion Criteria

Patients must not:

  • Have received prior treatment for Follicular Lymphoma
    Have had major surgery within the last 4 weeks
    Have any significant cardiovascular disease

Additional Info

All study visits will take place at Prebys Cancer Center in Hillcrest or Scripps Clinic Torrey Pines.

The following NCT# can be used to research more details on the ClinicalTrials.gov website (http://clinicaltrials.gov).

NCT06191744

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org